NVS: Novartis AG Stocks News on March 29, 2025

NVS

Morningstar Research

2 days ago

Analyst Report: Novartis AG

5 Large Drug Stocks to Watch as Industry Recovers

NVS

Zacks

4 days ago

5 Large Drug Stocks to Watch as Industry Recovers

Novartis to present new data at AAN, including seven-year disability outcomes and safety analysis of Kesimpta® in people with relapsing multiple sclerosis

NVS

GlobeNewswire

4 days ago

Novartis to present new data at AAN, including seven-year disability outcomes and safety analysis of Kesimpta® in people with relapsing multiple sclerosis

Tempero secures $70m to advance addiction treatment candidate

NVS

Pharmaceutical Technology

5 days ago

Tempero secures $70m to advance addiction treatment candidate

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

NVS

Zacks

5 days ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains

NVS

Zacks

5 days ago

Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains

Morgan Stanley says Fabhalta’s label leaves opportunity for Apellis’ Empaveli

NVS

TipRanks

7 days ago

Morgan Stanley says Fabhalta’s label leaves opportunity for Apellis’ Empaveli

FDA Approves Novartis Drug for Rare Kidney Disease Treatment

NVS

Zacks

8 days ago

FDA Approves Novartis Drug for Rare Kidney Disease Treatment

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy

NVS

Zacks

8 days ago

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals

NVS

Zacks

8 days ago

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals

FDA Approves Expanded Use Of Novartis Rare Disease Drug As Only Treatment For Rare Type Of Kidney Disease

NVS

Benzinga

8 days ago

FDA Approves Expanded Use Of Novartis Rare Disease Drug As Only Treatment For Rare Type Of Kidney Disease

AstraZeneca deepens China investment; Editas loses CFO to Dyne

NVS

BioPharma Dive

8 days ago

AstraZeneca deepens China investment; Editas loses CFO to Dyne

NVS

MT Newswires

8 days ago

Novartis Gets FDA Clearance for First Approved Treatment For Rare Kidney Disease

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) - the first and only treatment approved in C3 glomerulopathy (C3G)

NVS

PR Newswire

9 days ago

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) - the first and only treatment approved in C3 glomerulopathy (C3G)

Novartis Reports Updated Positive Data From Phase III SMA Program

NVS

Zacks

9 days ago

Novartis Reports Updated Positive Data From Phase III SMA Program

Novartis builds case for new SMA gene therapy

NVS

BioPharma Dive

9 days ago

Novartis builds case for new SMA gene therapy

Novartis reports Phase III efficacy and safety outcomes of SMA treatment

NVS

Clinical Trials Arena

9 days ago

Novartis reports Phase III efficacy and safety outcomes of SMA treatment

Teen’s death following Sarepta DMD gene therapy underscores a risk seen for decades

NVS

Pharma Voice

9 days ago

Teen’s death following Sarepta DMD gene therapy underscores a risk seen for decades

Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy

NVS

Benzinga

10 days ago

Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy

New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with SMA

NVS

GlobeNewswire

10 days ago

New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with SMA

Are You Looking for a High-Growth Dividend Stock?

NVS

Zacks

12 days ago

Are You Looking for a High-Growth Dividend Stock?

NVS

MT Newswires

12 days ago

Update: Market Chatter: Novartis Tracking US Reciprocal Tariff Policy 'Very Carefully'

NVS

MT Newswires

12 days ago

Sector Update: Health Care Stocks Decline Premarket Monday

NVS

MT Newswires

12 days ago

Market Chatter: Novartis Tracking US Reciprocal Tariff Policy 'Very Carefully'

Novartis is watching US reciprocal tariff policy 'very carefully', CEO says

NVS

Reuters

12 days ago

Novartis is watching US reciprocal tariff policy 'very carefully', CEO says

Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?

NVS

Zacks

15 days ago

Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

NVS

Zacks

16 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Why Novartis (NVS) is a Top Value Stock for the Long-Term

NVS

Zacks

17 days ago

Why Novartis (NVS) is a Top Value Stock for the Long-Term

NVS

Thomson Reuters StreetEvents

17 days ago

Q4 2024 Legend Biotech Corp Earnings Call

Molecular Partners AG (MLLCF) (FY 2024) Earnings Call Highlights: Strategic Shifts and ...

NVS

GuruFocus.com

21 days ago

Molecular Partners AG (MLLCF) (FY 2024) Earnings Call Highlights: Strategic Shifts and ...

Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting

NVS

GlobeNewswire

22 days ago

Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting

3 Top Cancer Biotechs to Keep An Eye On in 2025

NVS

Zacks

22 days ago

3 Top Cancer Biotechs to Keep An Eye On in 2025

ITM targets US approval for radiopharmaceutical after Phase III readout

NVS

Pharmaceutical Technology

23 days ago

ITM targets US approval for radiopharmaceutical after Phase III readout

Novartis AG (NVS): Among the Best Undervalued Stocks to Invest In Now

NVS

Insider Monkey

24 days ago

Novartis AG (NVS): Among the Best Undervalued Stocks to Invest In Now

Novartis Near Buy Point; Earns Near-Best Overall Rating

NVS

Investor's Business Daily

24 days ago

Novartis Near Buy Point; Earns Near-Best Overall Rating

Novartis Earnings Surprised The Street; Still Going Strong

NVS

Investor's Business Daily

25 days ago

Novartis Earnings Surprised The Street; Still Going Strong

NVS

MT Newswires

25 days ago

DA Davidson Downgrades Novartis to Neutral From Buy, Price Target is $120

Novartis Gets CHMP Opinion for Label Expansion of Fabhalta

NVS

Zacks

a month ago

Novartis Gets CHMP Opinion for Label Expansion of Fabhalta

3 Dividend Stocks That Are No-Brainer Buys Right Now

NVS

Motley Fool

a month ago

3 Dividend Stocks That Are No-Brainer Buys Right Now

NVS

Thomson Reuters StreetEvents

a month ago

Q4 2024 PTC Therapeutics Inc Earnings Call

Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)

NVS

GlobeNewswire

a month ago

Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)

Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)

NVS

GlobeNewswire

a month ago

Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)

PTC Therapeutics Inc (PTCT) Q4 2024 Earnings Call Highlights: Strong Financial Performance and ...

NVS

GuruFocus.com

a month ago

PTC Therapeutics Inc (PTCT) Q4 2024 Earnings Call Highlights: Strong Financial Performance and ...

NVS

Thomson Reuters StreetEvents

a month ago

Q4 2024 Schrodinger Inc Earnings Call

Schrodinger Inc (SDGR) Q4 2024 Earnings Call Highlights: Strong Software Growth Amidst Revenue ...

NVS

GuruFocus.com

a month ago

Schrodinger Inc (SDGR) Q4 2024 Earnings Call Highlights: Strong Software Growth Amidst Revenue ...

NVS

MT Newswires

a month ago

Sector Update: Health Care Stocks Slip in Afternoon Trading

Court Dismisses Novartis Challenge To Medicare Drug Price Negotiation Program

NVS

Benzinga

a month ago

Court Dismisses Novartis Challenge To Medicare Drug Price Negotiation Program

NVS

MT Newswires

a month ago

Update: Novartis Stockholder Sandoz to Reportedly Sell 26.5 Million Shares

NVS

MT Newswires

a month ago

Novartis Stockholder Sandoz to Reportedly Sell 26.5 Million Shares

Sandoz family to get $2.9 billion from offloading part of its Novartis stake

NVS

Reuters

a month ago

Sandoz family to get $2.9 billion from offloading part of its Novartis stake

Sandoz Family Pares Novartis Stake With $2.9 Billion Sale

NVS

Bloomberg

a month ago

Sandoz Family Pares Novartis Stake With $2.9 Billion Sale

NVS

MT Newswires

a month ago

Sector Update: Health Care Stocks Higher Late Afternoon

NVS

MT Newswires

a month ago

Sector Update: Health Care

NVS

MT Newswires

a month ago

Update: Market Chatter: Emasan Offering to Sell 1.2% Stake in Novartis

NVS

MT Newswires

a month ago

Market Chatter: Emasan Offering to Sell 1.2% Stake in Novartis

Here's Why Novartis (NVS) is a Strong Momentum Stock

NVS

Zacks

a month ago

Here's Why Novartis (NVS) is a Strong Momentum Stock

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

NVS

Zacks

a month ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Novartis AG (NVS): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

NVS

Insider Monkey

a month ago

Novartis AG (NVS): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Novartis AG (NVS): Among the Best Global Stocks to Buy According to Hedge Funds

NVS

Insider Monkey

a month ago

Novartis AG (NVS): Among the Best Global Stocks to Buy According to Hedge Funds

BMO Expands Canadian Depositary Receipt (CDR) Lineup with 10 New Listings from Europe and Japan

NVS

CNW Group

a month ago

BMO Expands Canadian Depositary Receipt (CDR) Lineup with 10 New Listings from Europe and Japan

HMRI and Novartis Australia sign MoU to expedite medical research

NVS

Pharmaceutical Technology

a month ago

HMRI and Novartis Australia sign MoU to expedite medical research

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs

NVS

Zacks

a month ago

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs

Is Novartis AG (NVS) the Best Foreign Dividend Stock to Buy According to Analysts?

NVS

Insider Monkey

a month ago

Is Novartis AG (NVS) the Best Foreign Dividend Stock to Buy According to Analysts?

Health Canada approves Novartis’ Fabhalta for PNH with haemolytic anaemia

NVS

Pharmaceutical Technology

a month ago

Health Canada approves Novartis’ Fabhalta for PNH with haemolytic anaemia

NVS

MT Newswires

a month ago

Novartis Faces 'Sharp Deceleration' in Growth in Mid-2025, UBS Says

Abcuro secures $200m as it eyes approval for rare muscle disease drug

NVS

Pharmaceutical Technology

a month ago

Abcuro secures $200m as it eyes approval for rare muscle disease drug

NVS

MT Newswires

2 months ago

Sector Update: Health Care Stocks Fall in Late Afternoon Trading

NVS

MT Newswires

2 months ago

Sector Update: Health Care Stocks Softer Tuesday Afternoon

NVS

MT Newswires

2 months ago

Sector Update: Health Care

NVS

MT Newswires

2 months ago

Novartis signs agreement to acquire Anthos for $925m upfront

Novartis Strikes Up to $3.1 Billion Deal to Buy Anthos Therapeutics

NVS

MT Newswires

2 months ago

Novartis Strikes Up to $3.1 Billion Deal to Buy Anthos Therapeutics

Novartis pays $925M to reel in a startup it helped launch

NVS

BioPharma Dive

2 months ago

Novartis pays $925M to reel in a startup it helped launch

NVS

MT Newswires

2 months ago

Novartis to Acquire Anthos Therapeutics for Up to $3.1 Billion

Novartis buys Blackstone's Anthos for up to $3.1 billion

NVS

Reuters

2 months ago

Novartis buys Blackstone's Anthos for up to $3.1 billion

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

NVS

GlobeNewswire

2 months ago

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

Is Novartis AG (NVS) The Best Annual Dividend Stock To Buy Now?

NVS

Insider Monkey

2 months ago

Is Novartis AG (NVS) The Best Annual Dividend Stock To Buy Now?

Novartis and Dawn Health introduce breast cancer support app

NVS

Medical Device Network

2 months ago

Novartis and Dawn Health introduce breast cancer support app

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

NVS

Zacks

2 months ago

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

Novartis Rises 5% Since Q4 Earnings: How Should You Play the Stock?

NVS

Zacks

2 months ago

Novartis Rises 5% Since Q4 Earnings: How Should You Play the Stock?

Pfizer taps former Novartis exec to lead cancer drug push

NVS

BioPharma Dive

2 months ago

Pfizer taps former Novartis exec to lead cancer drug push

Novartis AG (NVS): Among the Best Foreign Dividend Stocks to Invest In Now

NVS

Insider Monkey

2 months ago

Novartis AG (NVS): Among the Best Foreign Dividend Stocks to Invest In Now

Here's Why Novartis (NVS) is a Strong Value Stock

NVS

Zacks

2 months ago

Here's Why Novartis (NVS) is a Strong Value Stock

Radiopharmaceutical deals drive sector growth despite supply crisis

NVS

Pharmaceutical Technology

2 months ago

Radiopharmaceutical deals drive sector growth despite supply crisis

NVS

MT Newswires

2 months ago

Sector Update: Health Care Stocks Decline Tuesday Afternoon

Incyte Gears Up to Report Q4 Earnings: Here's What You Should Know

NVS

Zacks

2 months ago

Incyte Gears Up to Report Q4 Earnings: Here's What You Should Know

NVS

MT Newswires

2 months ago

Market Chatter: Novartis on Lookout for Next-Generation Obesity Drug Candidates

2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond

NVS

Motley Fool

2 months ago

2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond

NVS

Morningstar Research

2 months ago

Analyst Report: Novartis AG

Novartis AG (NVS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Outlook ...

NVS

GuruFocus.com

2 months ago

Novartis AG (NVS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Outlook ...

Novartis Pares Gains As Its Bread-And-Butter Drug Faces Looming Competition

NVS

Investor's Business Daily

2 months ago

Novartis Pares Gains As Its Bread-And-Butter Drug Faces Looming Competition

Novartis Posts Q4 Earnings and Sales Beat, Shares Gain

NVS

Zacks

2 months ago

Novartis Posts Q4 Earnings and Sales Beat, Shares Gain

NVS

MT Newswires

2 months ago

Ionis Pharmaceuticals Says Data Readout From Pelacarsen Study Is Delayed

Novartis Ag (NVS) Q4 2024 Earnings Call Transcript

NVS

Motley Fool

2 months ago

Novartis Ag (NVS) Q4 2024 Earnings Call Transcript

Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

NVS

Zacks

2 months ago

Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest Moneymaker

NVS

Investor's Business Daily

2 months ago

Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest Moneymaker

NVS

The Wall Street Journal

2 months ago

Health Care Roundup: Market Talk

Novartis sets ‘ambitious’ target; Skyrizi, Rinvoq sales climb

NVS

BioPharma Dive

2 months ago

Novartis sets ‘ambitious’ target; Skyrizi, Rinvoq sales climb

Novartis Q4 Earnings: Revenue And EPS Beat, CEO Dismisses Entresto Patent Expiration Worries

NVS

Benzinga

2 months ago

Novartis Q4 Earnings: Revenue And EPS Beat, CEO Dismisses Entresto Patent Expiration Worries

NVS

Associated Press Finance

2 months ago

Latest Novartis AG (NVS) News on March 29, 2025

Share on Social Networks: